Table 1.
Localization | Type of receptor | REFERENCES |
---|---|---|
Dog | ||
Central nervous system | CB1: claustrum and neocortex, cerebellar cortex, midbrain, medulla oblongata, globus pallidus and substantia nigra, trigeminus, basal ganglia, cochlear nucleus, olfactory bulb and hippocampus. |
Pirone et al. 2016 Freundt-Revilla et al. 2017 Silver 2019 Kostic et al. 2023 Chiocchetti et al. 2019 |
CB1s decrease in dogs with idiopathic epilepsy and increase in dogs with structural epilepsy. | ||
Peripheral nerve system | CB1: neurons, myelinating Schwann cells and dorsal root ganglia. | |
CB2: neuron, Schwann cells, blood vessel smooth muscle cells, pericyte-like cells TRPV1: neuron, satellite glial cells | ||
GPR55: neuron, satellite glial cells | ||
PARRα: satellite glial cells, endothelial cells. | ||
Immune Cells | CB1 and CB2: peripheral blood mononuclear cells, macrophages. |
Brown et al. 2023 Silver 2019 |
CB2: mast cells. | ||
Skin | CB1 and CB2: basal e suprabasal epidermal cell layers, inner epithelial root sheaths cell of hair follicles, reserve cells of sebaceous glands, secretory and ductal cells of sweat glands. | Campora et al. 2012 |
CB1 and CB2: perivascular cells with mast cell morphology, fibroblasts, and endothelial cells. | ||
CB2: basal e suprabasal cells of outer epithelial root sheaths of hair follicles and cells of arrector pili muscles. | ||
Stronger immunoreactivity in skin of dogs with atopic dermatitis. | ||
CB1, CB2, GPR55, TRPV1, TRPA1 and PPARα: basal and suprabasal keratinocytes. | Chiocchetti et al. 2022a | |
Significant upregulation of CB2 and TRPA1 in samples from dogs with atopic dermatitis. | ||
CB2, GPR55, TRPV1 and TRPA1: inflammatory infiltrate of the skin of atopic dogs (mast cells, macrophages/dendritic cells, T lymphocytes). | Chiocchetti et al. 2022b | |
GPR55: calprotectin immunoreactive neutrophils. | ||
CB1: hair follicles (bulb and suprabulbar region of both primary and secondary hair follicles). | Mercati et al. 2012 | |
Gastrointestinal tract | CB1: enterochromaffin cells of pylorus, small and large intestine; some lamina propria and epithelial cells of small and large intestine. | Galiazzo et al. 2018 |
CB2: endothelial and smooth muscle cells of mucosal and submucosal blood vessels, smooth muscle cells of the muscularis mucosae, mast cells of the lamina propria, unidentified immunocytes within intestinal lymphatic nodules, muscular layers of the intestine (small intestine > colon > pylorus), neurons and glial cells of intestinal submucosal plexus. | ||
GPR55: lamina propria (macrophages, plasma cells and mast cells) and epithelial cells, enterochromaffin cells, muscular layers. | ||
PPARα: lamina propria cells, epithelial cells, blood vessels, smooth muscle cells of the muscularis mucosae and tunica muscularis, glial cells of submucosal and myenteric plexus. | ||
Hip and Stifle Joints | CB1, CB2 and GPR55: synoviocytes. | Zamith Cunha et al. 2023a |
CB2 and GPR55: macrophages, neutrophils and vascular cells. | ||
Mast cell tumors | CB1 and CB2: highly expressed in low-grade mast cell tumors. | Rinaldi et al. 2022 |
Salivary gland | CB1: epithelial ductal cells. | Dall’Aglio et al. 2010 |
Embryo | CB1: epithelial immunoreactivity detected in several structures of central and peripheral nervous system, several nervous and non-nervous structures of sensory organs (inner ear structures, the developing eye and the olfactory epithelium), and thyroid. | Pirone et al. 2015 |
Cat | ||
Skin | CB1 and CB2: epidermal layers and hair follicle sheaths, differentiated sebocytes and hair bulb matrical cells. | Miragliotta et al. 2018 |
CB2: sweat glands. | ||
PPAR: basal keratinocytes of epidermis, outer epithelial root sheath and isolated dermal papillae. | ||
Overexpression in cats with dermatitis related to hypersensitivity, with the main distribution changes being suprabasal for CB1, dermal for CB2 and marked expression of PPAR-α in hyperplastic epidermis and perivascular infiltrate. | ||
Oral mucosa | CB1: TRPA1: mucosal epithelium. | Polidoro et al. 2021 |
CB2 and GPR55: subepithelial inflammatory cells. | ||
Upregulation in cats with chronic gingivostomatitis. | ||
Gastrointestinal tract | CB1: gastric epithelial cells, intestinal enteroendocrine cells, goblet cells, lamina propria mast cells, and enteric neurons. | Stanzani et al. 2020. |
CB2: intestinal enteroendocrine cells, enterocytes, and macrophages. | ||
GPR55: intestinal enteroendocrine cells macrophages, immunocytes, and myenteric plexus neurons. | ||
PPARα: immunocytes, smooth muscle cells, and enteroglial cells. | ||
TRPA1: enteric neurons and intestinal goblet cells. | ||
Arterial smooth muscle cells | CB1. | Gebremedhin et al. 1999 |
Ovary and oviduct | CB1: tertiary follicle granulosa cells, luteal cells, oviduct ciliated cells. | Pirone et al. 2017 |
Femoropatellar synovial membrane | CB1: in cats with synovitis. | Ruel et al. 2022 |
Horse | ||
Metacarpophalangeal synovial membrane | CB1: synoviocytes. | Miagkoff et al. 2023; Zamith Cunha et al. 2023c |
CB2, TRPV1 and PPARα: synoviocytes, blood vessels and fibroblasts. | ||
GPR55: synoviocytes and endothelial cells. | ||
CB1 and CB2 overexpressed in presence of synovitis; CB1 decreased in horses with osteoarthritis. | ||
Ileum | CB1: enterocytes, enteric neurons and enteric glial cells of the myenteric and submucosal plexus. | Galiazzo et al. 2021 |
CB2: enterocytes, subclasses of immune cells in the lamina propria. | ||
PPARα: peripheral smooth muscle cells of the longitudinal muscular layer, neurons and glial cells. | ||
TRPA1: neurons of the myenteric and submucosal plexus and the nerve fibers. | ||
Skin | CB1 and CB2: epidermis, dermal fibroblast-like cells, sebaceous glands, sweat glands. | Kupczyk et al. 2022; |
CB2: hair follicles, endothelial cells and their perivascular cells (pericytes, vascular smooth muscle). | ||
Trigeminal ganglion | CB1, CB2, TRPV1, GPR55 and PARRγ. | Zamith Cunha et al. 2023b |
Dorsal root ganglia | CB1, CB2, PPARα and γ, TRPV1, TRPA1, GPR3 and GPR55. |
Chiocchetti et al. 2021 Galiazzo et al. 2022 |
CB1: cannabinoid receptor type 1; CB2: cannabinoid receptor type 2; GPR55 and GPR3: G protein-coupled receptor 55 and 3; PPAR: peroxisome proliferator-activated receptor; TRPV1: transient receptor potential vanilloid 1; TRPA1: transient receptors potential ankyrin 1